CLINICAL_TRIALS
trial_result
· 2016-01-27
Clinical Trial Update: An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain [Phase 3]
Summary
Open-label extension results for duloxetine in participants with chronic low back pain from a Phase 3 trial update.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Back Pain Lower Back Chronic | Phase 3 | Status: COMPLETED | Results posted: 2016-01-27